Studies Show Why Clinical Trials are Failing
The European Medicines Agency met in December to discuss clinical trials, but the results were not favorable. They delivered a message that no one in the trials community wanted to hear: they are pushing back legislation on clinical medicine trials.
Many hoped to see progress with new trial rules for Europe, but earlier confirmations showed that the regulations -- which were finalized in May 2014 and said to begin in May 2016 -- would be pushed back to 2017 at least. This latest announcement pushes them back even further, to a likely date of October 2018.
Thousands of drugs are synthesized during the research and development stage, but just one in 5,000 will actually make it through clinical trials and the approval of the U.S. Food and Drug Administration or other governing body. So ...



